Employees covered by Vanderbilt University Medical Center health plans and employees covered by the Metro Nashville Public Schools health plan can now enroll in two new MyHealth Bundles: MyUrologyHealth for the treatment of kidney stones and MyRecoveryHealth for the treatment of substance use disorder.

Vanderbilt researchers have discovered another acid resistance mechanism for UTI-causing E. coli, laying the foundation for targeted antibacterial therapies.

Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.

Research from Vanderbilt-Ingram Cancer Center has revealed new information about the molecular pathways of cribriform prostate cancer.

Gender differences in the pain experiences and treatment needs of people with a urologic pain syndrome could be used to improve interventions, Vanderbilt researchers report.

Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs.

A generous donation is leading to the Hassell Franklin Lectureship for the Division of Urologic Oncology at Vanderbilt University Medical Center.